Immunomodulatory activity of boswellic acids (Pentacyclic triterpene acids) from Boswellia serrata

Phytotherapy Research

Volumn 10, Issue 2, 1996, Pages 107-112

  Sharma, M L ^a   Kaul, A ^a   Khajuria, A ^a   Singh, S ^a   Singh, G B ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Boswellia serrata; Boswellic acids; Cell mediated immunity; Humoral immunity; Lymphocyte proliferation; Phagocytosis

Indexed keywords

ALLOANTIGEN; AZATHIOPRINE; BETAMETHASONE; BOSWELLIA SERRATA EXTRACT; BOSWELLIC ACID; COMPLEMENT FIXING ANTIBODY; CONCANAVALIN A; HUMORAL ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LEVAMISOLE; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; PLANT EXTRACT; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOTOXICITY; LEUKOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHAGOCYTOSIS; PRIMARY IMMUNE RESPONSE; RAT; SECONDARY IMMUNE RESPONSE; SHEEP ERYTHROCYTE; SPLEEN CELL;

EID: 0029983417     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199603)10:2<107::AID-PTR780>3.0.CO;2-3     Document Type: Article

References (23)

1. 4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med. 57, 203-207.
2. Ammon, H. P. T., Safayhi, H., Mack, T., and Sabieraj, J. (1993). Mechanism of antiinflammatory actions of curcumine and boswellic acids. J. Ethnopharmacol. 38, 113-119.
3. Bach, F. H., and Hirschhorn, N. (1964). Lymphocyte interaction: a potential histocompatibility test in vitro. Science 143, 813-814.
4. Benacerraf, B. (1978). A hypothesis to relate the specificity of T lymphocytes and the activity of I region specific Ir genes in macrophages and B lymphocytes. J. Immunol. 120, 1809-1832.
5. Dunnett, C. W. (1964). New tables for multiple comparisons with control. Biometrics 20, 482-491.
6. Erhardt, C. C. (1984). Immunosuppressive therapy for rheumatoid arthritis. In, Rheumatoid Arthritis: The Treatment Controversy, ed. by D. Goddard and R. Butler, pp. 97-118. Sheridan House, New York.
7. Goodwin, J. S., and Ceuppens, J. L. (1983). Effect of non-steroidal anti-inflammatory drugs on immune function. Sem. Arthritis Rheum. 13 (Suppl. 1), 134-143.
8. Kapil, A., and Moza, N. (1992). Anti-complementary activity of boswellic acids - an inhibitor of C3-convertase of the classical complement pathway. Int. J. Immunopharmaco;. 14, 1139-1143.
9. Lehrer, R. I. (1981). Ingestion and destruction of Candida albicans. In, Methods for Studying Mononuclear Phagocytes, ed. by D. O. Adams, P. J. Edelson and H. Koreon, pp. 693-708. Academic Press, New York.
10. Littler, T. R. (1990). Anti-rheumatic drugs. In, Anti-Rheumatic Drugs, ed. by M. C. L. E. Orme, pp. 189-216. Pergamon Press, New York.
11. Mackenzie, A. R., Pick, C. R., Sibley, P. R., and White, B. P. (1978). Suppression of rat adjuvant disease by cyclo-phosphamide pretreatment, evidence for an antibody mediated component in the pathogenesis of the disease. Clin. Exp. Immunol. 32, 86-98.
12. Nelson, D. S., and Mildenhall, P. (1967). Studies on cytophilic antibodies. 1. The production by mice of macrophage cytophilic antibodies to sheep erythrocytes: relationship to the production of other antibodies and the development of delayed type hypersensitivity. Aust. J. Exp. Biol. Med. Sci. 45, 113-130.
13. Safayhi, H., Mack, T., Sabieraj, J., Anazodo, M. I., Subramanian, L. R., and Ammon, H. P. T. (1992). Boswellic acids: novel specific, nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 261, 1143-1146.
14. Salmon, J. A., and Garland, L. G. (1991). Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents. Prog. Drug Res. 37, 9-90.
15. Schwartz, R. S. (1966). Specificity of immunosuppression by antimetabolites. Fed. Proc. Fed. Am. Soc. Exp. Biol. 25, 165-168.
16. Sharma, M. L., Bani, S., and Singh, G. B. (1989). Antiarthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int. J. Immunopharmacol. 11, 647-652.
17. Sharma, M. L., Khajuria, A., Kaul, A., and Chand, D. (1992). Immunopharmacological properties of azepine [2,1-b] quinazolin-12(6H)-one-7,8,9,10-tetrahydro (RLX). Int. J. Immunopharmacol. 14, 979-986.
18. Sharma, O. P., and Tripathy, N. K. (1986). Karyotypic diversity in genus Mystus (Bagridae : Pisces). Cytologia 51, 1-9.
19. Singh, G. B., Singh, Surjeet and Bani, S. (1993). Boswellic acids - anti-inflammatory, anti-arthritic and anti-pyretic. Drugs of the Future 18, 307-309.
20. Spreafico, F., and Anaclerio, A. (1977). Immunosuppressive agents. In, Immunopharmacology, ed. by J. W. Hadden, R. G. Coffey, and F. Spreafico, pp. 245-278. Plenum, New York.
21. Stroehmann, I. (1986). Immunosuppressive therapy of rheumatic diseases. Rheumatology 9. 42-45.
22. Woolnough, J. A. and Lafferty, K. J. (1979). Generation of homogenous populations of alloreactive T cells in vitro. Aust. J. Exp. Biol. Med. Sci. 57, 127-139.
23. Zvaifler, N. (1973). Immunopathogenesis of joint inflammation in rheumatoid arthritis. Adv. Immunol. 16, 265-336.